Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Lymphoma 223Lymphoma, Large B-Cell, Diffuse 208Lymphoma, Non-Hodgkin 148Leukemia, Lymphocytic, Chronic, B-Cell 138Lymphoma, Follicular 130Lymphoma, Mantle-Cell 117Lymphoma, B-Cell, Marginal Zone 78Leukemia 72Burkitt Lymphoma 62Waldenstrom Macroglobulinemia 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Lymphoma, B-Cell 45Recurrence 39Lymphoma, Large-Cell, Immunoblastic 33Hodgkin Disease 26Neoplasms 16Dendritic Cell Sarcoma, Interdigitating 16Lymphoma, Large-Cell, Anaplastic 14Leukemia, Myeloid, Acute 14Myelodysplastic Syndromes 12Leukemia, Hairy Cell 12Multiple Myeloma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Hematologic Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Prolymphocytic 8Leukemia, Myeloid, Accelerated Phase 8Intraocular Lymphoma 8Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7

Interventions

Ipilimumab 106Nivolumab 101pembrolizumab 90aldesleukin 72Cyclophosphamide 46Interleukin-2 45Temozolomide 36Dacarbazine 32trametinib 31dabrafenib 30fludarabine phosphate 29incomplete Freund's adjuvant 27Bevacizumab 26sargramostim 25Vemurafenib 25fludarabine 22binimetinib 21Radiosurgery 21Paclitaxel 20encorafenib 19Carboplatin 19CTLA-4 Antigen 18cobimetinib 16atezolizumab 15Radiotherapy 14Biopsy 14Sorafenib 13MART-1 Antigen 12talimogene laherparepvec 11montanide ISA 51 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Melanoma × Rituximab × Clear all
NCT03719131 2025-04-22

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Emory University

Phase 2 Active not recruiting
15 enrolled 10 charts
Dermatologic

Melanoma

NCT02142335 2014-05-20

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

California Cancer Assocaties for Research & Excellence

Phase 2 Unknown
17 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡